GNLKQ Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume510.66K
Average Volume (3M)0.00
Market Cap
$10.60K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta247.82
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding265,019,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GNLKQ FAQ
What was GeneLink Inc’s price range in the past 12 months?
GeneLink Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is GeneLink Inc’s market cap?
GeneLink Inc’s market cap is $10.60K.
When is GeneLink Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GeneLink Inc’s earnings last quarter?
Currently, no data Available
Is GeneLink Inc overvalued?
According to Wall Street analysts GeneLink Inc’s price is currently Overvalued.
Does GeneLink Inc pay dividends?
GeneLink Inc does not currently pay dividends.
What is GeneLink Inc’s EPS estimate?
GeneLink Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GeneLink Inc have?
GeneLink Inc has 265,019,000 shares outstanding.
What happened to GeneLink Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GeneLink Inc?
Currently, no hedge funds are holding shares in GNLKQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GeneLink Inc
GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.
Technical Analysis
―
Scinai Immunotherapeutics
―
NewcelX
―
CDT Equity
―
Virax Biolabs Group Ltd. Class A
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors